Risk factors for esotropia reoperation revealed

Article

Underaction of the lateral rectus muscle could be a risk factor for reoperation of congenital esostropia, claims an investigation in the Journal of Pediatric Ophthalmology and Strabismus.

Underaction of the lateral rectus muscle could be a risk factor for reoperation of congenital esostropia, claims an investigation in the Journal of Pediatric Ophthalmology and Strabismus.

Dr Z. Rajavi et al., Ophthalmic Research Centre, Shahid Beheshti University of Medical Sciences, Tehran, Iran, conducted a study on 157 children with congenital esotropia, who were divided into two groups after a minimum of one operation. The patients included those with a deviation greater than 10 PD or a history of reoperation.

Risk factors such as age at first operation and primary congenital esotropia of less than 30 or more than 50 PD inferior oblique muscle overaction, dissociated vertical deviation, lateral rectus muscle underaction, and A-V pattern with reoperation were recorded.

Reoperation was required in 32.4% of children who presented with residual esotrpia greater than 15 PD after the three-month follow-up. Congenital esotropia greater than 30 PD and lateral rectus muscle underaction of −1 to −2 were statistically different between the two groups and were found to be risk factors of reoperation.

Please click here to view the abstract.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.